Online inquiry

IVTScrip™ mRNA-Human ARHGEF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25006MR)

This product GTTS-WK25006MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF1 protein. This product can be used in Naive CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_004706.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9138
UniProt ID Q92888
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25006MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8705MR IVTScrip™ mRNA-Human 3C4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA 3C4
GTTS-WK21540MR IVTScrip™ mRNA-Human ANKS6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKS6
GTTS-WK10963MR IVTScrip™ mRNA-Human ACTL6A, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ACTL6A
GTTS-WK28692MR IVTScrip™ mRNA-Human ASAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASAP2
GTTS-WK6577MR IVTScrip™ mRNA-Human CD63, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD63
GTTS-WK12792MR IVTScrip™ mRNA-Human ADAM19, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM19
GTTS-WK17923MR IVTScrip™ mRNA-Human ANKRD37, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD37
GTTS-WK6921MR IVTScrip™ mRNA-Human Go-alpha, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Go-alpha
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW